Patent: 6,855,338
✉ Email this page to a colleague
Summary for Patent: 6,855,338
| Title: | Anti-tumor therapies comprising a combination of a cartilage extract and an anti-neoplastic agent providing high efficacy and low toxic side effects |
| Abstract: | This invention described a novel use for cartilage extract, namely a shark cartilage extract, in a combined anti-tumor therapy. The cartilage extract is used in combination with anti-neoplastics. The combined therapy provides for a higher anti-tumor efficacy with no concomitant increase, even better with a decrease, of toxic side effects. |
| Inventor(s): | Dupont; Eric (Saint-Nicolas, CA) |
| Assignee: | Les Laboratoires Aeterna, Inc. (Quebec, CA) |
| Application Number: | 10/087,041 |
| Patent Claims: | see list of patent claims |
Details for Patent 6,855,338
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
|---|---|---|---|---|---|---|---|
| Recordati Rare Diseases, Inc. | ELSPAR | asparaginase | For Injection | 101063 | 01/10/1978 | ⤷ Try a Trial | 2017-03-11 |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |
